Previous Article | Next Article 
Journal of Clinical Microbiology, May 2001, p. 1840-1844, Vol. 39, No. 5
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.5.1840-1844.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Simple Method for Determining Biovar and Serovar
Types of Ureaplasma urealyticum Clinical Isolates Using
PCR-Single-Strand Conformation Polymorphism Analysis
David
Pitcher,1,*
Margaret
Sillis,2 and
Janet A.
Robertson3
Respiratory and Systemic Infection
Laboratory, Central Public Health Laboratory, London NW9
5HT,1 and Public Health Laboratory,
Norwich NR2 3TX,2 United Kingdom, and
Department of Medical Microbiology and Immunology, University
of Alberta, Edmonton, Alberta T6G 2H7, Canada3
Received 29 September 2000/Returned for modification 9 January
2001/Accepted 23 February 2001
 |
ABSTRACT |
Ureaplasma urealyticum has been associated with
urethritis in men, obstetric problems in women, and respiratory
distress syndrome in preterm infants. U. urealyticum can be
divided into two biovars comprising 14 serovars. Partial sequences of
genes encoding the multiple-banded antigens of the cell surface are
known. Using a commercially available precast DNA mutation detection
gel system, we have developed a simple and reproducible
PCR-single-strand conformation polymorphism analysis method for
differentiating the biovars of this species that reveals five patterns
among the 14 serovars and enables clinical isolates to be typed
directly from broth cultures.
 |
INTRODUCTION |
Ureaplasma urealyticum is a
common commensal of the urogenital tract in both men and women. It has
been implicated in male nongonococcal urethritis (27) and
associated with a number of obstetric conditions, including
chorioamnionitis and chronic respiratory distress in neonates, often
with poor prognosis (1, 3). Use of polyclonal antisera
raised against whole ureaplasmal cells has identifed 14 serovars
(22). As shown earlier by DNA hybridization studies on
serovars 1 to 8, these can be divided into two clusters or biovars. DNA
homology between the biovars was less than 60% and sufficiently
different to have separate species suggested for each of the biovars
(5). More recently other phenotypic and genotypic traits,
including results of restriction fragment analysis (7) and
16S rRNA sequencing (20), and genome size (21) have confirmed this finding. Currently, separate
species status is being sought for each of the biovars (J. A. Robertson, personal communication).
Biovar 1 (parvo) consists of serovars 1, 3, 6, and 14, and biovar 2 (T960) consists of serovars 2, 4, 5, 7, 8, 9, 10, 11, 12, and 13 (22). For many years there has been speculation about the
association of particular serovars with disease. For example, in one
study in which the role of U. urealyticum in urinary tract disease was investigated, serotyping identified serovar 6 as the predominant type in urine samples (9). In another study, a statistical association was found between the occurrence of serovar 4 in women who had a history of recurrent abortions compared with healthy
pregnant women (16). Despite these findings there has been
no conclusive evidence linking a particular serovar with a disease. In
part, this could reflect difficulties in interpreting serological
typing results. Multiple cross-reactions are common, and clinical
samples frequently contain two or more serovars that cannot casually be
separated (26). Robertson et al. (19) were unable to ascribe any correlation between serovars isolated
from tissues of subjects experiencing spontaneous and therapeutic abortion.
The difficulty in interpreting the results obtained in these studies
was partly due to polyclonal antisera directed at the dominant antigens
of the organism. A full set of set of monoclonal antibodies (MAbs)
against serovar-specific antigens has recently been developed and
established that polyreactivity, a disadvantage of polyclonal
serotyping, was not encountered when using MAbs (6). MAbs
have been used to identify multiple-banded antigens responsible for
serovar specificity on the cell surface (34). Sequence
variation in the genes encoding these antigens (mba genes) has been exploited to partially differentiate serovars using
combinations of restriction enzymes or DNA amplification with panels of
primers (12, 15, 29). However, these methods all require
multistep procedures.
Single-strand conformation polymorphism (SSCP) analysis was originally
developed to detect allelic variation in human genetic disorders
(18). Double-stranded DNA is denatured, and the
single-stranded products are separated by gel electrophoresis under
accurately controlled, nondenaturing conditions. During its migration
through the gel, each strand assumes a folded conformation dependent on its internal base pairing and therefore on its sequence.
The migration distances of the conformers visualized as bands on the
gel are reproducible and are determined by the structure. Base
substitutions or deletions can alter the conformations, causing mobility shifts in the migration patterns and revealing sequence divergence in the specific genomic region amplified. In a small (100- to 200-bp) PCR product, as little as one base change can be detected by
this method (2, 4)
Although SSCP analysis has not yet found wide acceptance in
bacteriology, it has been used for the detection of rifampin-resistant mutants (rpoB gene) of Mycobacterium tuberculosis
(28) and to subtype Borrelia burgdorferi
isolates (16S rRNA gene) (31). Bacterial 16S ribosomal DNA
(rDNA) from clinical isolates has also been identified using
fluorescent primers in a PCR followed by SSCP analysis in an automated
DNA sequencer (30, 32).
Using commercially available precast gels in a horizontal
electrophoresis system, we investigated the possibility of genotyping U. urealyticum clinical isolates from the gel patterns of
single-stranded conformers of PCR-amplified products of their
mba genes.
 |
MATERIALS AND METHODS |
Strains, specimens, and culture conditions.
Stock reference
cultures were obtained from the American Type Culture Collection under
accession numbers ATCC 27813 (serovar 1), 27814 (serovar 2), 27815 (serovar 3), 27816 (serovar 4), 27817 (serovar 5), 27818 (serovar 6),
27819 (serovar 7), 27618 (serovar 8), 33175 (serovar 9), 33699 (serovar
10), 33695 (serovar 11), 33696 (serovar 12), 33698 (serovar 13), and
33697 (serovar 14). These were maintained in the freeze-dried state and
cultured in 4 ml of U4 broth (10).
Fluid clinical samples (endotracheal and nasopharyngeal aspirates) were
inoculated into 2 ml of arginine-urea broth (bioMérieux, Basingstoke, United Kingdom) (24). Swabs were dipped into
the broth and swirled briefly. All cultures were incubated at 37°C and inspected daily for growth.
Eighteen isolates from tissues of subjects who had experienced
abortion, whose serovars had been previously established using polyclonal antiserum and a colony epifluorescence method (19, 25), were cultured in broth, and the cells were centrifuged and
resuspended in 70% ethanol until the DNA was extracted. The preparations used for PCR-SSCP analyses were later passages than those
used for serotyping.
DNA extraction.
Cells were harvested by centrifugation of
broth cultures at 10,000 × g for 10 min. Pellets were
washed twice in sterile phosphate-buffered saline (pH 7.4; Oxoid,
Basingstoke, United Kingdom), resuspended by vigorously vortexing in
500 µl of sterilized Chelex 100 suspension (10%, wt/vol, in PCR
quality water) (Bio-Rad, Hemel Hempstead, United Kingdom), and
incubated in a 56°C water bath for 30 min. Suspensions were vortexed
for 20 s, heated at 100°C for 8 min, and rapidly cooled on ice.
Finally, samples were vortexed again, centrifuged at 10,000 × g for 5 min (17). The supernatants were transferred to clean tubes and stored at
20°C until required.
Amplification of mba gene fragment.
In PCR
mixtures for SSCP analysis, the forward primer was UMS
120
(5'-TGCAATCTTTATATGTTTTCGTT-3'), located 120 bases upstream from the start codon of the mba sequence of serovar 3 (29). Two similar reverse primers downstream of this
position were UMA +46 (5'-CCTAGTGTAATTGCTCAAAATTT-3') and
UMA +46* (5'-CCTAATGTCATAGCTMAGAATTT-3'), which were used
together to account for degeneracies in bases in this region. Reaction
mixtures (50 µl) contained 50 mM KCl, 2.5 mM MgCl2, 15 mM
Tris-HCl (pH 8.0), a 200 µM concentration of each deoxyribonucleotide
triphosphate, 20 pmol of each primer and 1.5 U of Taq DNA
polymerase (Perkin-Elmer, Warrington, United Kingdom). Chelex extract
(10 µl) was added. Samples were overlaid with oil, and 45 cycles of
95°C for 1 min, 54°C for 1 min, and 72°C for 1 min were carried
out, followed by a 72°C, 10-min extension period. Reactions were
performed in an Omnigene thermocycler (Hybaid, Ashford, United Kingdom).
SSCP gel electrophoresis.
To 10 µl of PCR product, 10 µl
denaturing buffer (1 ml of formamide containing 0.25% bromophenol
blue, mixed immediately before use with 10 µl of 1 M NaOH) was added;
the mixture was vortexed briefly, heated on a PCR heating block at
95°C for 5 min, and immediately cooled on ice; and 5 µl of 50%
glycerol added.
The electrophoresis system was set up 1 h before the run. An SEA
2000 tank (Elchrom Scientific, Cham, Switzerland), which possesses a
buffer-circulating pump, was filled with 1.5 liters of TAE buffer (30 mM Tris-acetate, 0.75 mM EDTA buffer [pH 8.2]). The external water
jacket was connected to a temperature-controlled circulating water bath.
The temperature of the circulating buffer was adjusted to 9°C before
the MDA 26-lane gels (Elchrom Scientific) were placed in the tank.
Before loading the samples, the buffer-circulating pump was turned off.
Wells were loaded with 20 µl of ice-cold samples. Electrophoresis was
carried out for 30 min at 48 V, the buffer pump was turned on, and
electrophoresis continued for a further 17.5 h at 48 V. Gels were
stained with SYBR gold (Molecular Probes, Leiden, The Netherlands)
(1/10,000 in 10 mM TAE buffer) for 40 min, examined on a
transilluminator at 254 nm, and photographed using a SYBR green filter
and 667 Polaroid film.
The electrophoresis unit employed in this study enabled 26 samples,
including controls to be run simultaneously. The approximate times
required for processing 26 cultures were 1 h for DNA extraction, 15 min for preparation of the samples, 18 h for electrophoresis overnight, and 40 min for SYBR gold staining.
 |
RESULTS |
SSCP grouping of reference strains.
The extraction of DNA from
broth culture sediments using Chelex to suppress inhibitors of
Taq DNA polymerase, when applied to both standard strain
cultures and clinical isolates, yielded successful PCRs. Careful
control of the electrophoresis conditions allowed identification of gel
banding patterns which unambiguously differentiated biovars 1 and 2 of
U. urealyticum directly from the broth cultures of standard
strains representing the 14 established serovars of this species and
enabled placement of the serovars into five mba gene groups.
A 100-bp ladder was included to estimate gel-to-gel reproducibility and
does not relate to the size of the conformers, whose migration
distances are based on the shape of their folded structures rather than
their sequence length (Fig. 1). Biovar 1 gave
a PCR product of 173 bp from which three conformer band patterns were
obtained; serovars 1 and 6 gave distinct patterns, and those of
serovars 3 and 14 were identical. There was less discrimination among
the serovars of biovar 2, where the 217-bp product gave rise to two
patterns. Pattern 2A contained serovars 2, 5, 8, and 9, and pattern 2B
contained serovars 4, 7, 10, 11, 12, and 13. From these results we
predicted that all isolates could be typed to one of the following
mba groups: biovar 1 (1, 3/14, and 6) and biovar 2 (2A and
2B).

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 1.
PCR-SSCP patterns of the reference strains of U. urealyticum used to define serovars. Lanes 1 to 14, serovars 1 to
14; lanes M, 100-bp ladder. ssDNA and dsDNA, single-stranded and
double-stranded DNA, respectively.
|
|
Correlation of SSCP analysis with serotyping.
First we
examined the DNA from 18 coded, previously serotyped isolates of the
abortion study (19). Their biovars had been predicted
based on experience with serotyping, and more recently the isolates had
been typed to the biovar level by 16S rRNA gene PCRs (23).
PCR-SSCP band patterns for these are shown in Fig. 2. Correlation of the biovar designation
between the two types of PCR (16S rRNA and mba gene
sequences) and between PCRs and the serotyping results were exact
except for strain RH1139 (Table 1). On the
basis of serology, RH1139, indicated as carrying serovars 11 and 13 of
biovar 2, was placed in biovar 1 by both types of PCR.

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 2.
PCR-SSCP patterns of serologically confirmed strains of
U. urealyticum listed in Table 1. Lane 1, control serovar 1;
lanes 2 to 5, RH303, RH313, RH1087, and RH872; lane 6, control serovar
3; lanes 7 to 10, RH297, RH541, RH666, and RH1139; lane 11, control
serovar 6; lanes 12 to 14, RH555, RH677, and RH191; lane 15, control
serovar 2; lanes 16 to 18, NIH5, T960, and RH479; lane 19, control
serovar 4; lanes 20 to 23, RH122, RH507, RH539, and RH799; lane M,
100-bp ladder.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Correlation of blind-tested PCR-SSCP analysis-determined
groups with biovar as determined by PCR of 16S rDNA and serovar and
biovar as determined by serotyping
|
|
For 12 of the other 17 strains, the SSCP analysis and serotyping
results were in agreement. The five remaining strains did not show such
clear correlation. Isolate RH872 reacted with antiserum to serovar 3 but was identified as mba gene group 1 by SSCP analysis; isolate RH799, which reacted with antisera to serovars 12 and 13 (both
in biovar 2), was identified correctly as group 2B by SSCP analysis,
but it also reacted with serovar 9 antiserum, which is associated with
biovar 2A. Similarly, isolate RH191 reacted with antisera to serovars 3 and 14 as well as 6, but only mba gene group 6 was amplified.
From the SSCP patterns two cultures of mixed biovars (RH297 and RH541)
and one (RH479) of mixed mba gene groups within a single biovar were detected. In the case of isolate RH297, serotyping resulted
in reactions with antisera to serovars 6 and 13, which belong to
biovars 1 and 2, respectively, and which should correlate with
mba gene groups 6 and 2B. However, the SSCP analysis showed genes from each biovar but biovar 2 was associated with mba
gene group 2A not 2B.
In culture RH541, both serotyping and SSCP analysis identified serovar
3, but SSCP analysis also indicated the presence of biovar 2A genes,
and in RH479, for which serotyping revealed only the presence of
serovar 4, equivalent to the mba gene group 2B, SSCP
analysis also detected the presence of group 2A.
Application of PCR-SSCP analysis to clinical isolates.
Secondly, we subjected the deposits from 44 Ureaplasma broth
culture isolates from clinical specimens to PCR-SSCP analysis in order
to confirm that the five SSCP patterns would cover most isolates. These
specimens were randomly selected and consisted of 15 cultures from the
tracheal and nasopharyngeal aspirates of neonates, both full term and
preterm, and 29 cultures from high vaginal swabs taken from pregnant
and from nonpregnant woman (Table 2). All
gave easily recognizable patterns that could be assigned to one of the
above groups; no mixed groups were detected. All five groups were
represented among the isolates.
 |
DISCUSSION |
Genes encoding the multiple banded antigens (mba genes)
of U. urealyticum have been fully sequenced for biovar 1 (serovar 3; GenBank accession no. L20329) and biovar 2 (serovar 10; GenBank accession no. U50459). The 3' region of these genes shows
marked differences in long stretches of tandem repeat units where
serovar specificity is determined (34; X. Zheng, L. J. Teng, H. L. Watson, J. L. Glass, A. Blanchard, and G. H. Cassell, GenBank accession no. L20329 and U50459). Close to the 5' end
of the gene, a 45-bp deletion in the biovar 1 gene accounts for the difference in PCR product length between biovars 1 and 2 (29, 33,
34). PCRs amplifying parts of the first 400 to 500 bases of the
5' end of the mba gene region including 125 bases upstream of the start codon followed by restriction endonuclease typing have
enabled the partial differentiation of serovars into groups (29). More detailed sequence data were determined for this
region for all 14 serovars by Kong et al. (15), who
devised a stepwise system of biotyping and partial serovar
identification based on PCR using two primer pairs and followed by
restriction enzyme analysis of the products. Knox and colleagues
(12, 13) have sequenced the mba 5' regions
(nucleotide positions
104 to 207) of 33 clinical isolates of U. urealyticum and compared them to the standard serovar sequences.
Using a nested PCR with two outer and six inner primers, they defined
nine subtypes within the biovar 1 isolates, including two subtypes of
serovar 1, five of serovar 3, and two of serovar 6. Biovar 2 could be
divided into two subtypes. In certain instances, the differences
between subtypes of the same serovar was a single base difference. They
also applied random amplified polymorphic DNA analysis (RAPD) to these
isolates and, using seven primers, differentiated 13 RAPD subtypes.
They concluded that RAPD provided the greatest discrimination as a
typing method for U. urealyticum.
To date, significant structural and functional differences have not
been identified beyond the biovar level, and neither biovars or
subdivisions of them have been convincingly correlated with disease
states. Unlike RAPD and restriction digest patterns of nested PCR
products, PCR-SSCP analysis requires a single set of primers and a
single amplification step, making it a more-efficient approach for
subdividing large numbers of ureaplasmas. Groups were designated on the
basis of the SSCP patterns of serovar reference strains (Fig. 1), and
most of the serovars of isolates from the abortion study were broadly
in agreement with their SSCP groups. The discrepant results are
indicated in Table 1. One isolate (RH1139), when serotyped, belonged to
biovar 2, but both 16S rDNA PCR and SSCP analysis placed it in biovar
1. The reason for this anomaly could not be explained. In two other
instances where serotyping indicated mixed serovars, only one SSCP
pattern was detected. These findings could represent greater precision
of the SSCP analysis or changes in relative populations of subtypes in
mixed cultures on later passages or the sensitivity of the methodologies.
In three instances, mixed patterns were observed on SSCP gels, but each
component could clearly be identified as belonging to one of the
designated groups and probably indicating mixed cultures. Although the
results of gene-based methods are expected to be more easily
reproducible than those of phenotyping, experience has taught us that
typing cloned, laboratory-adapted strains is much easier than working
with wild-type isolates (26). The serotyped isolates that
were mba genotyped in this study emphasize this lesson. They
had not been cloned; serotyping, biotyping, and PCR-SSCP analysis were
not performed on identical cultures. All strains tested in this study
provided unambiguous SSCP results, and the method could be used to
group clinical isolates as shown in Table 2. However, because these
were uncloned, randomly acquired isolates, we did not attempt to
correlate the group designation with the pathogenic status of the
patient. PCR-SSCP analysis did not detect any mixed groups among these
specimens, although mixtures of serovars are commonly encountered on
serotyping. In a mixed population of serovars, culture in broth could
favor the growth of more-vigorous strains or those present at the
highest initial density, and serotyping may reflect this. With PCR,
there could be preferential amplification of the most abundant DNA
template, resulting in a single group being detected.
Ideally, sequencing the mba gene would be the most accurate
way of typing isolates, but it is a time-consuming, expensive, and
skilled procedure and not a practical proposition for analyzing large
numbers of isolates. However, PCR-SSCP analysis could be a convenient
way of rapid screening prior to selecting strains for sequencing. For
most diagnostic laboratories that are unable to employ sequencing, the
procedure could be used routinely to analyze clinical isolates.
The two biovars of U. urealyticum can now be readily
differentiated by PCRs based upon differences in the 16S rRNA
(11, 23), the 16S-23S rRNA intergenic region
(8), and the mba genes (29).
Genotypic methods based on the mba gene are effectively
replacing the 14-member-serotyping scheme established with polyvalent antisera (12-15). Unlike MAbs, the hyperimmune sera used
for serotyping may contain more than one antibody to each of the
multiple antigens present in the whole-cell preparations used as
immunogens. It has been shown, for instance, that many antisera contain
antibodies to the biovar-specific urease enzyme (25). The
infinitely greater complexity of antigen-antibody reactions compared to
the variations in nucleotide sequences of a single gene means that
complete correlation cannot be expected. In this study, we exploited
sequence differences within the mba gene both to separate
the two biovars and also to indicate subgroups consisting of one or
more serovars. A single PCR will thus allow differentiation of U. urealyticum into five groups. Its application to controlled
clinical studies may help to further an understanding of ureaplasmal
pathogenicity. We propose that the typing of U. urealyticum
strains from a wide variety of sources could be achieved more rapidly,
more cheaply, and in greater numbers by this technique than by
previously described methods. Direct identification of these genotypes
in clinical specimens is our next goal.
 |
ACKNOWLEDGMENT |
We thank Robert C. George for constructive appraisal of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Respiratory and
Systemic Infection Laboratory, Central Public Health Laboratory, 61 Colindale Ave., London NW9 5HT, United Kingdom. Phone: 44 (0) 208 200 4400. Fax: 44 (0) 208 205 6528. E-mail:
dpitcher{at}phls.nhs.uk.
 |
REFERENCES |
| 1.
|
Abele-Horn, M.,
C. Wolff,
P. Dressel,
F. Pfaff, and A. Zimmerman.
1997.
Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease.
J. Clin. Microbiol.
35:1199-1202[Abstract].
|
| 2.
|
Ainsworth, P. J.,
L. C. Surh, and M. B. Coulter-Mackie.
1991.
Diagnostic single strand conformational polymorphism (SSCP): a simplified non-radioactive method as applied to a Tay-Sachs B1 variant.
Nucleic Acids Res.
19:405-406[Free Full Text].
|
| 3.
|
Cassell, G. H.,
K. B. Waites,
H. L. Watson,
D. T. Crouse, and R. Harasawa.
1993.
Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.
Clin. Microbiol. Rev.
6:69-87[Abstract/Free Full Text].
|
| 4.
|
Chaubert, P.,
D. Bautista, and J. Benhattar.
1993.
An improved method for rapid screening of DNA mutations by non-radioactive single-strand conformation polymorphism procedure.
BioTechniques
15:586[Medline].
|
| 5.
|
Christiansen, C.,
F. T. Black, and E. A. Freundt.
1981.
Hybridization experiments with deoxyribonucleic acid from Ureaplasma urealyticum serovars I to VIII.
Int. J. Syst. Bacteriol.
31:259-262[Abstract/Free Full Text].
|
| 6.
|
Echahidi, F.,
G. Muyldermans,
S. Lauwers, and A. Naessens.
2000.
Development of monoclonal antibodies against Ureaplasma urealyticum serotypes and their use for serotyping clinical isolates.
Clin. J. Diagn. Lab. Immunol.
7:563-567[Abstract/Free Full Text].
|
| 7.
|
Harasawa, R.,
K. Dybvig,
H. L. Watson, and G. H. Cassell.
1991.
Two genomic clusters among the 14 serovars of Ureaplasma urealyticum.
Syst. Appl. Microbiol.
14:393-396.
|
| 8.
|
Harasawa, R., and Y. Kanamoto.
1999.
Differentiation of two biovars of Ureaplasma urealyticum based on the 16S-23S rRNA intergenic spacer region.
J. Clin. Microbiol.
37:4135-4138[Abstract/Free Full Text].
|
| 9.
|
Hewish, M. J.,
D. F. Birch, and K. F. Fairley.
1986.
Ureaplasma urealyticum serotypes in urinary tract disease.
J. Clin. Microbiol.
23:149-154[Abstract/Free Full Text].
|
| 10.
|
Howard, C. J.,
R. N. Gourlay, and J. Collins.
1978.
Serological studies with bovine ureaplasma (T-mycoplasma) Int.
J. Syst. Bacteriol.
28:473-477[Abstract/Free Full Text].
|
| 11.
|
Jacobs, E.,
M. Vonski,
G. W. Stemke, and J. A. Robertson.
1994.
Identification of Ureaplasma biotypes.
Med. Microbiol. Lett.
3:31-35.
|
| 12.
|
Knox, C. L.,
P. Giffard, and P. Timms.
1998.
The phylogeny of Ureaplasma urealyticum based on the mba gene fragment.
Int. J. Syst. Bacteriol.
48:1323-1331[Abstract/Free Full Text].
|
| 13.
|
Knox, C. L., and P. Timms.
1998.
Comparison of PCR, and random amplified polymorphic DNA PCR for detection and typing of Ureaplasma urealyticum in specimens from pregnant women.
J. Clin. Microbiol.
36:3032-3039[Abstract/Free Full Text].
|
| 14.
|
Kong, F.,
G. James,
M. Zhenfang,
S. Gordon,
B. Wang, and G. L. Gilbert.
1999.
Phylogenetic analysis of Ureaplasma urealyticum: support for the establishment of a new species, Ureaplasma parvum.
Int. J. Syst. Bacteriol.
49:1879-1889[Abstract/Free Full Text].
|
| 15.
|
Kong, F.,
X. Zhu,
W. Wang,
X. Zhou,
S. Gordon, and G. L. Gilbert.
1999.
Comparative analysis and serovar-specific identification of multiple-banded antigen genes of Ureaplasma urealyticum biovar 1.
J. Clin. Microbiol.
37:538-543[Abstract/Free Full Text].
|
| 16.
|
Naessens, A.,
W. Foulon,
J. Breynaert, and S. Lauwers.
1988.
Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications.
J. Clin. Microbiol.
26:319-322[Abstract/Free Full Text].
|
| 17.
|
Ochert, A. S.,
A. Boulter,
W. Birnbaum,
N. W. Johnson, and C. G. Teo.
1994.
Inhibitory effects of salivary fluids on PCR: potency and removal.
PCR Methods Appl.
3:365-368[Medline].
|
| 18.
|
Orita, M.,
Y. Suzuki,
T. Sekiya, and K. Hayashi.
1989.
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.
Genomics
5:874-879[CrossRef][Medline].
|
| 19.
|
Robertson, J. A.,
L. H. Honore, and G. W. Stemke.
1986.
Serotypes of Ureaplasma urealyticum in spontaneous abortion.
Pediatr. Infect. Dis.
5:S270-S272[Medline].
|
| 20.
|
Robertson, J. A.,
L. A. Howard,
C. L. Zinner, and G. W. Stemke.
1994.
Comparison of the 16S rRNA genes within the T960 and parvo biovars of ureaplasmas isolated from humans.
Int. J. Syst. Bacteriol.
44:836-838[Abstract/Free Full Text].
|
| 21.
|
Robertson, J. A.,
L. Pyle,
G. W. Stemke, and L. R. Finch.
1990.
Ureaplasma urealyticum shows diverse genome size by pulse-field electrophoresis.
Nucleic Acids Res.
18:1451-1455[Abstract/Free Full Text].
|
| 22.
|
Robertson, J. A., and G. W. Stemke.
1982.
Expanded serotyping system scheme for Ureaplasma urealyticum strains isolated from humans.
J. Clin. Microbiol.
15:873-878[Abstract/Free Full Text].
|
| 23.
|
Robertson, J. A.,
A. Vekris,
C. Bébéar, and G. W. Stemke.
1993.
Polymerase chain reaction using 16S rRNA sequences distinguishes the two biovars of Ureaplasma urealyticum.
J. Clin. Microbiol.
31:824-830[Abstract/Free Full Text].
|
| 24.
|
Sillis, M.
1993.
Genital mycoplasmas revisited an evaluation of a new culture medium.
Br. J. Biomed. Sci.
50:89-91[Medline].
|
| 25.
|
Stemke, G. W., and J. A. Robertson.
1981.
Modified colony indirect epifluorescence test for serotyping Ureaplasma urealyticum and an adaptation to detect common antigenic specificity.
J. Clin. Microbiol.
14:582-584[Abstract/Free Full Text].
|
| 26.
|
Stemke, G. W., and J. A. Robertson.
1985.
Problems associated with serotyping strains of Ureaplasma urealyticum.
Diagn. Microbiol. Infect. Dis.
3:311-320[CrossRef][Medline].
|
| 27.
|
Taylor-Robinson, D., and P. M. Furr.
1997.
Genital mycoplasma infections.
Wien. Klin. Wochenschr.
109:578-583[Medline].
|
| 28.
|
Telenti, A.,
P. Imboden,
F. Marchesi,
T. Schmidheini, and T. Bodmer.
1993.
Direct, automated detection of rifampicin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis.
Antimicrob. Agents Chemother.
37:2054-2058[Abstract/Free Full Text].
|
| 29.
|
Teng, L.-J.,
X. Zheng,
J. L. Glass,
H. L. Watson,
J. Tsai, and G. H. Cassell.
1994.
Ureaplasma urealyticum biovar specificity and diversity are encoded in multiple-banded antigen gene.
J. Clin. Microbiol.
32:1464-1469[Abstract/Free Full Text].
|
| 30.
|
Turenne, C. Y.,
E. Witwicki,
D. J. Hoban,
J. A. Karlowsky, and A. M. Kabani.
2000.
Rapid identification of bacteria from positive blood cultures by fluorescence-based PCR-single stranded conformation polymorphism analysis of the 16S rRNA gene.
J. Clin. Microbiol.
38:513-520[Abstract/Free Full Text].
|
| 31.
|
Weinecke, R.,
O. M. Koch,
U. Neubert,
U. Göbel, and M. Volkenandt.
1993.
Detection of subtype-specific nucleotide sequence differences in a Borrelia burgdorferi specific gene segment by analysis of conformational polymorphisms of cRNA molecules.
Med. Microbiol. Lett.
2:239-246.
|
| 32.
|
Widjojoatmodjo, M. N.,
A. D. C. Fluit, and J. Verhoef.
1995.
Molecular identification of bacteria by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene.
J. Clin. Microbiol.
33:2601-2606[Abstract].
|
| 33.
|
Zheng, X.,
K. Lau,
M. Frazier,
G. H. Cassells, and H. L. Watson.
1996.
Epitope mapping of the variable repetitive region within the MB antigen of Ureaplasma urealyticum.
Clin. Diagn. Lab. Immunol.
3:774-778[Abstract].
|
| 34.
|
Zheng, X.,
L.-J. Teng,
H. L. Watson,
J. L. Glass,
A. Blanchard, and G. H. Cassell.
1995.
Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation.
Infect. Immun.
63:891-898[Abstract].
|
Journal of Clinical Microbiology, May 2001, p. 1840-1844, Vol. 39, No. 5
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.5.1840-1844.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Waites, K. B., Katz, B., Schelonka, R. L.
(2005). Mycoplasmas and Ureaplasmas as Neonatal Pathogens. Clin. Microbiol. Rev.
18: 757-789
[Abstract]
[Full Text]